Karyopharm Therapeutics Inc. Financial Ratios — KPTI Stock

Profitability (USD)

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Return on Common Equity (%)	- -	- -	- -	-41.9	-58.34	-60.77	-88.43	-114.13	-171.36	-391.29	- -	- -	- -	- -	- -
Return on Assets (%)	- -	-372.3	-42.56	-40.03	-54.24	-55.37	-71.52	-68.42	-62.75	-64.56	-40.13	-49.83	-47.81	-37.75	-143.71
Return on Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Return on Invested Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Gross Margin (%)	100	100	100	100	100	100	100	100	94.11	97.5	98.38	96.68	96.62	95.86	95.93
EBITDA Margin (%)	-6,728.95	-2,487.07	-8,735.4	-32,979.48	-47,376.8	-71,438.31	-8,088.79	-590.55	-460.47	-158.1	-46.46	-90.14	-88.34	-82.01	-61.9
Operating Margin (%)	-6,783.55	-2,506.31	-8,772.61	-33,120.52	-47,630.4	-71,903.9	-8,133.21	-592.97	-462.85	-159	-46.84	-90.53	-88.71	-82.24	-62.1
Incremental Operating Margin (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Pretax Margin (%)	-6,783.55	-2,505.99	-8,771.83	-33,090.39	-47,272.4	-71,063.64	-8,032.46	-588.02	-487.98	-181.31	-59.01	-105	-97.77	-52.58	-134.18
Profit Margin (%)	-6,783.55	-2,505.99	-8,771.83	-33,090.39	-47,272.4	-71,153.9	-8,036.39	-588.1	-488.08	-181.59	-59.14	-105.23	-97.99	-52.62	-134.21
Net Income to Common Margin (%)	-6,783.55	-2,505.99	-8,771.83	-33,090.39	-47,272.4	-71,153.9	-8,036.39	-588.1	-488.08	-181.59	-59.14	-105.23	-97.99	-52.62	-134.21
Effective Tax Rate (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Dvd Payout Ratio (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Sustainable Growth Rate (%)	- -	- -	- -	-41.9	-58.34	-60.77	-88.43	-114.13	-171.36	-391.29	- -	- -	- -	- -	- -

Credit (USD)

Credit Ratios API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Total Debt	- -	- -	- -	- -	- -	- -	- -	103	125	131	181	179	177	195	234
ST Debt	- -	- -	- -	- -	- -	- -	- -	- -	2	2	2	3	3	25	22
LT Debt	- -	- -	- -	- -	- -	- -	- -	103	123	129	178	176	174	170	212
Total Debt/EBITDA	- -	- -	- -	- -	- -	- -	- -	-0.57	-0.66	-0.77	-1.85	-1.26	-1.37	-1.63	-2.58
Net Debt/EBITDA	0.64	0.02	4.61	1.99	0.49	0.45	0.53	0.09	0.1	-0.19	0.22	-0.25	-0.92	-1.05	-1.84
Total Debt/EBIT	- -	- -	- -	- -	- -	- -	- -	-0.57	-0.66	-0.76	-1.84	-1.26	-1.37	-1.63	-2.58
Net Debt/EBIT	0.63	0.02	4.59	1.99	0.49	0.45	0.53	0.09	0.1	-0.19	0.22	-0.25	-0.92	-1.05	-1.83
EBITDA to Interest Expense	- -	- -	- -	-75,523	- -	- -	- -	-71.86	-12.03	-6.3	-3.74	-5.66	-5.42	-3.18	-1.97
EBITDA-CapEx/Interest Expense	- -	- -	- -	-78,357	- -	- -	- -	-72.81	-12.05	-6.3	-3.96	-5.67	-5.42	-3.19	-1.97
EBIT to Interest Expense	- -	- -	- -	-75,846	- -	- -	- -	-72.16	-12.1	-6.33	-3.77	-5.69	-5.44	-3.19	-1.98
Interest Expense	- -	- -	- -	- -	- -	- -	- -	2	16	27	26	25	24	37	46
Common Equity/Total Assets	-175.12	-2,126.39	97.92	93.85	92.07	89.94	71.81	53.69	16.87	16.15	-26.1	-4.65	-56.65	-113.14	-270.19
Long-Term Debt/Equity (%)	- -	- -	- -	- -	- -	- -	- -	56.05	247.24	255.63	- -	- -	- -	- -	- -
Long-Term Debt/Capital (%)	- -	- -	- -	- -	- -	- -	- -	35.92	70.53	71.12	176.66	108.49	425.65	1,994.36	-356.76
Long-Term Debt/Total Assets (%)	- -	- -	- -	- -	- -	- -	- -	30.09	41.72	41.28	58.39	49.19	72.25	103.19	195.2
Total Debt/Equity (%)	- -	- -	- -	- -	- -	- -	- -	56.05	250.54	259.43	-226.65	-1,075.13	-129.96	-104.57	-79.75
Total Debt/Capital (%)	- -	- -	- -	- -	- -	- -	- -	35.92	71.47	72.18	178.96	110.26	433.76	2,286.63	-393.81
Total Debt/Total Assets (%)	- -	- -	- -	- -	- -	- -	- -	30.09	42.28	41.89	59.15	50	73.62	118.31	215.47
Net Debt to Equity	51.47	1.4	-100.67	-72.83	-29.42	-30.61	-53.29	-8.38	-38.17	63.33	26.57	-209.64	-87.14	-67.14	-56.79
Net Debt/Capital (%)	33.98	1.38	14,997.5	-268.06	-41.68	-44.11	-114.11	-9.15	-41.65	33.43	23.63	128.23	-1,039.21	-231.43	-138.79
EBITDA	-10	-16	-34	-76	-118	-110	-130	-179	-188	-171	-97	-142	-129	-119	-90
EBITDA-CapEx	-11	-16	-34	-78	-120	-110	-130	-182	-189	-171	-103	-142	-129	-119	-90
Operating Income (Loss)	-10	-16	-34	-76	-119	-111	-131	-180	-189	-172	-98	-142	-130	-119	-91

Liquidity (USD)

Liquidity Ratios API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Cash Ratio	3.08	0.2	47.38	16.72	11.61	7.86	2.96	7	5.65	4.14	3.1	4.22	2.76	1.18	0.69
Current Ratio	3.24	0.49	47.98	16.89	11.74	7.99	3	7.13	6.01	4.59	3.74	5.31	3.37	1.7	1.12
Quick Ratio	3.08	0.2	47.38	16.72	11.61	7.86	2.96	7	5.82	4.35	3.41	4.93	3.14	1.51	0.98
CFO/Avg Current Liab	- -	-7.66	-11.6	-6.6	-6.86	-5.34	-2.24	-3.3	-4.09	-3.01	-1.6	-2.14	-1.37	-1.58	-0.82
Common Equity/Total Assets	-175.12	-2,126.39	97.92	93.85	92.07	89.94	71.81	53.69	16.87	16.15	-26.1	-4.65	-56.65	-113.14	-270.19
Long-Term Debt/Equity (%)	- -	- -	- -	- -	- -	- -	- -	56.05	247.24	255.63	- -	- -	- -	- -	- -
Long-Term Debt/Capital (%)	- -	- -	- -	- -	- -	- -	- -	35.92	70.53	71.12	176.66	108.49	425.65	1,994.36	-356.76
Long-Term Debt/Total Assets (%)	- -	- -	- -	- -	- -	- -	- -	30.09	41.72	41.28	58.39	49.19	72.25	103.19	195.2
Total Debt/Equity (%)	- -	- -	- -	- -	- -	- -	- -	56.05	250.54	259.43	-226.65	-1,075.13	-129.96	-104.57	-79.75
Total Debt/Capital (%)	- -	- -	- -	- -	- -	- -	- -	35.92	71.47	72.18	178.96	110.26	433.76	2,286.63	-393.81
Total Debt/Total Assets (%)	- -	- -	- -	- -	- -	- -	- -	30.09	42.28	41.89	59.15	50	73.62	118.31	215.47
CFO/Total Liabilities	-43.01	-53.13	-920.11	-379.88	-550.59	-465.17	-145.03	-100.69	-77.83	-61.04	-27.82	-39.9	-24.62	-36.38	-18.78
CFO/CapEx	-22.74	-128.17	-531.4	-18.15	-66.4	-1,205.59	-1,188.98	-67.34	-926.32	-1,105.06	-18.75	-1,267.41	- -	-897.79	- -
Altman's Z-Score	-6.37	-70.97	123.4	53.22	14.1	8.91	0.04	-1.24	-2.12	-2.81	-4.23	-4.56	-8.85	-14.21	-23.81

Working Capital (USD)

Working Capital Ratios API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Accounts Receivable Turnover	- -	- -	- -	- -	- -	- -	- -	- -	10.4	10.42	11.86	4.51	3.94	5.03	5.13
Days Sales Outstanding	- -	- -	- -	- -	- -	- -	- -	- -	35.09	35.02	30.77	80.85	92.54	72.54	71.15
Inventory Turnover	- -	- -	- -	- -	- -	- -	- -	- -	13.91	1.81	1.01	1.25	1.36	1.54	1.36
Days Inventory Outstanding	- -	- -	- -	- -	- -	- -	- -	- -	26.23	201.73	362.1	291.62	268.36	236.43	269.26
Accounts Payable Turnover	- -	- -	- -	- -	- -	- -	- -	- -	1.04	1.84	1.61	2.44	1.28	1.87	1.15
Accounts Payable Turnover Days	- -	- -	- -	- -	- -	- -	- -	- -	352.47	198.26	227.11	149.81	286.1	194.99	316.8
Cash Conversion Cycle	- -	- -	- -	- -	- -	- -	- -	- -	-291.15	38.49	165.76	222.66	74.8	113.98	23.6
Inventory to Cash Days	- -	- -	- -	- -	- -	- -	- -	- -	8.85	-166.7	-331.33	-210.78	-175.82	-163.89	-198.11
Inventories	- -	- -	- -	- -	- -	- -	- -	- -	- -	3	4	4	3	5	4
Raw Materials	- -	- -	- -	- -	- -	- -	- -	- -	- -	2	2	1	1	1	1
Work In Process	- -	- -	- -	- -	- -	- -	- -	- -	- -	1	2	2	2	4	3
Finished Goods	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	1	1	- -	- -
Other Inventory	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -

Enterprise Value (USD)

Enterprise Value API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Market Capitalization	- -	- -	678	1,223	475	393	475	569	1,252	1,143	486	385	99	85	135
- Cash & Cash Equivalents	7	- -	156	151	58	50	69	118	129	86	190	135	52	62	61
+ Preferred Equity and Hybrid Capital	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Minority/Non Controlling Interest	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Total Debt	- -	- -	- -	- -	- -	- -	- -	103	125	131	181	179	177	195	234
Enterprise Value	-7	- -	522	1,017	299	264	329	344	1,115	1,025	438	286	85	171	305
Total Capital	-13	-28	155	207	198	162	129	286	174	182	101	162	41	9	-59
Total Debt/Capital (%)	- -	- -	- -	- -	- -	- -	- -	35.92	71.47	72.18	178.96	110.26	433.76	2,286.63	-393.81
Total Debt / EV	- -	- -	- -	- -	- -	- -	- -	0.3	0.11	0.13	0.41	0.63	2.08	1.14	0.77
EV/Sales	- -	- -	1,347.74	4,440.64	1,196.87	1,712.82	204.71	11.33	27.26	9.48	2.09	1.82	0.58	1.18	2.09
EV/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/Cash Flow to Firm	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/Free Cash Flow to Firm	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Diluted Market Cap	- -	- -	139	1,164	472	352	440	532	1,186	1,114	483	278	99	86	80
Diluted Enterprise Value	-7	- -	-17	1,014	413	303	371	516	1,182	1,159	473	322	224	218	254
EV per Share	- -	- -	264.43	466.48	125.14	94.46	99.5	84.78	255.76	207.93	86.79	37.9	11.1	20.34	16.64
TTM Sales	- -	1	- -	- -	- -	- -	2	30	41	108	210	157	146	145	146
TTM EBITDA	-10	-16	-34	-76	-118	-110	-130	-179	-188	-171	-97	-142	-129	-119	-90
TTM Operating Income	-10	-16	-34	-76	-119	-111	-131	-180	-189	-172	-98	-142	-130	-119	-91
TTM Cash Flow to Firm	-9	-16	-30	-51	-94	-84	-74	-157	-175	-133	-81	-125	-69	-90	-30
TTM Free Cash Flow to Firm	-8	-15	-30	-49	-93	-84	-74	-154	-175	-133	-75	-124	-69	-90	-30

Multiples (USD)

Valuation Multiples API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Price/Free Cash Flow	- -	- -	-4.6	-23.95	-5.09	-4.18	-5.98	-3.39	-6.22	-6.96	-4.76	-1.86	-1.07	-0.67	-1.07
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Enterprise Value	-7	- -	522	1,017	299	264	329	344	1,115	1,025	438	286	85	171	305
Low Price	- -	- -	232.2	316.65	149.85	72.45	112.05	120	58.8	200.7	66.3	36.75	9.26	8.71	3.51
EV/Sales	- -	- -	1,347.74	4,440.64	1,196.87	1,712.82	204.71	11.33	27.26	9.48	2.09	1.82	0.58	1.18	2.09
EV/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Earnings	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Earnings Average	- -	- -	-3.29	-14.41	-6.73	-2.83	-3.63	-4.73	-2.82	-6.4	-5.61	-2.97	-1.7	-1.55	-0.35
Price/Earnings High	- -	- -	-4.59	-20.12	-11.58	-4.78	-5.2	-6.91	-6.2	-10.86	-10.9	-7.29	-3.89	-3.11	-0.69
Price/Earnings Low	- -	- -	-2.77	-8.67	-3.01	-1.65	-2.66	-2.55	-1.22	-4.91	-2.68	-1.21	-0.49	-0.93	-0.2
Price/Book Value	- -	- -	4.37	5.91	2.39	2.42	3.67	3.11	25.15	22.61	-6.1	-23.11	-0.73	-0.46	-0.46
Price/Book Value Average	- -	- -	3.51	5.55	4.04	2.13	3.9	4.94	11.94	25.49	-8.8	-40.71	-1.8	-0.66	-0.39
Price/Book Value High	- -	- -	4.9	7.74	6.95	3.6	5.59	7.2	26.24	43.26	-17.09	-100.05	-4.11	-1.32	-0.78
Price/Book Value Low	- -	- -	2.96	3.34	1.81	1.25	2.86	2.66	5.15	19.57	-4.2	-16.65	-0.52	-0.39	-0.22
Price/Tangible Book Value	- -	- -	4.37	5.91	2.39	2.42	3.67	3.11	25.15	22.61	-6.1	-23.11	-0.73	-0.46	-0.46
Price/Tangible Book Value Average	- -	- -	3.51	5.55	4.04	2.13	3.9	4.94	11.94	25.49	-8.8	-40.71	-1.8	-0.66	-0.39
Price/Tangible Book Value High	- -	- -	4.9	7.74	6.95	3.6	5.59	7.2	26.24	43.26	-17.09	-100.05	-4.11	-1.32	-0.78
Price/Tangible Book Value Low	- -	- -	2.96	3.34	1.81	1.25	2.86	2.66	5.15	19.57	-4.2	-16.65	-0.52	-0.39	-0.22
Price/Sales	- -	- -	359.04	5,083.68	1,886.41	2,287.93	274.25	17.53	29.01	10.3	2.3	1.77	0.68	0.57	0.55
Price/Sales Average	- -	- -	288.39	4,768.91	3,181.92	2,012.47	291.53	27.84	13.77	11.62	3.32	3.12	1.67	0.82	0.46
Price/Sales High	- -	- -	402.32	6,656.78	5,475.43	3,401.44	418.1	40.61	30.27	19.72	6.45	7.67	3.81	1.64	0.93
Price/Sales Low	- -	- -	242.71	2,870.19	1,423.36	1,176.86	213.63	14.98	5.94	8.92	1.58	1.28	0.48	0.49	0.26
Price/Cash Flow	- -	- -	-4.59	-22.63	-5.02	-4.18	-5.97	-3.34	-6.22	-6.95	-4.51	-1.86	-1.07	-0.65	-1.07
Price/Cash Flow Average	- -	- -	-3.68	-21.23	-8.46	-3.67	-6.35	-5.31	-2.95	-7.84	-6.5	-3.28	-2.63	-0.93	-0.9
Price/Cash Flow High	- -	- -	-5.14	-29.63	-14.56	-6.21	-9.1	-7.74	-6.49	-13.3	-12.63	-8.06	-6	-1.86	-1.81
Price/Cash Flow Low	- -	- -	-3.1	-12.78	-3.78	-2.15	-4.65	-2.86	-1.27	-6.02	-3.1	-1.34	-0.76	-0.56	-0.51
Price/Free Cash Flow Average	- -	- -	-3.69	-22.46	-8.59	-3.68	-6.35	-5.39	-2.95	-7.84	-6.87	-3.28	-2.63	-0.97	-0.9
Price/Free Cash Flow High	- -	- -	-5.15	-31.36	-14.78	-6.21	-9.11	-7.86	-6.49	-13.31	-13.34	-8.06	-6	-1.94	-1.81
Price/Free Cash Flow Low	- -	- -	-3.11	-13.52	-3.84	-2.15	-4.66	-2.9	-1.27	-6.02	-3.28	-1.34	-0.76	-0.58	-0.51
EV/Sales Average	- -	- -	1,003.24	4,350.73	2,970.4	1,924.08	271.61	29.31	14.43	12.34	3.29	4.6	2.53	1.76	1.96
EV/Sales High	- -	- -	1,558.75	6,333.42	5,279.7	3,474.62	408.21	42.99	31.84	20.65	6.44	10.89	4.69	2.6	2.75
EV/Sales Low	- -	- -	780.46	2,356.66	1,199.72	991.27	187.55	15.54	6.16	9.57	1.55	2.05	1.34	1.41	1.62
EV/EBITDA Average	0.64	0.02	-11.48	-13.19	-6.27	-2.69	-3.36	-4.96	-3.13	-7.81	-7.09	-5.1	-2.87	-2.14	-3.17
EV/EBITDA High	0.64	0.02	-17.84	-19.2	-11.14	-4.86	-5.05	-7.28	-6.91	-13.06	-13.87	-12.08	-5.31	-3.17	-4.44
EV/EBITDA Low	0.64	0.02	-8.93	-7.15	-2.53	-1.39	-2.32	-2.63	-1.34	-6.05	-3.33	-2.27	-1.52	-1.72	-2.63
EV/EBIT Average	0.63	0.02	-11.44	-13.14	-6.24	-2.68	-3.34	-4.94	-3.12	-7.76	-7.03	-5.08	-2.85	-2.13	-3.16
EV/EBIT High	0.63	0.02	-17.77	-19.12	-11.08	-4.83	-5.02	-7.25	-6.88	-12.99	-13.76	-12.03	-5.28	-3.17	-4.42
EV/EBIT Low	0.63	0.02	-8.9	-7.12	-2.52	-1.38	-2.31	-2.62	-1.33	-6.02	-3.31	-2.26	-1.51	-1.72	-2.62
Last Price	- -	- -	343.5	560.85	198.6	140.85	143.85	140.4	287.25	231.9	96.3	51	12.98	10.14	7.36
High Price	- -	- -	384.9	734.4	576.45	209.4	219.3	325.35	299.7	443.7	269.7	220.8	73.05	29.25	12.45
Enterprise Value Average	-7	- -	388	996	743	296	436	889	590	1,334	691	722	370	255	287
Enterprise Value High	-7	- -	603	1,450	1,320	535	655	1,304	1,302	2,232	1,352	1,710	684	378	401
Enterprise Value Low	-7	- -	302	540	300	153	301	471	252	1,034	325	321	196	205	237

Shares Outstanding	2	2	2	2	2	3	3	4	4	5	5	8	8	8	18
Diluted Weighted Avg Shares	1	1	- -	2	2	3	3	4	4	5	5	5	8	8	11
Basic Weighted Avg Shares	1	1	- -	2	2	3	3	4	4	5	5	5	8	8	11
Revenue per Share	0.23	0.97	0.96	0.11	0.11	0.06	0.52	8.01	9.9	22.5	41.84	28.78	19.17	17.88	13.36
EBITDA per Share	-15.66	-24.14	-83.57	-36.38	-49.88	-43.98	-42.43	-47.31	-45.59	-35.58	-19.44	-25.94	-16.94	-14.66	-8.27
Operating Income per Share	-15.79	-24.33	-83.93	-36.54	-50.15	-44.27	-42.66	-47.5	-45.83	-35.78	-19.6	-26.05	-17.01	-14.7	-8.3
Basic EPS, GAAP	-15.79	-24.33	-83.92	-36.51	-49.77	-43.8	-42.15	-47.11	-48.32	-40.87	-24.75	-30.28	-18.79	-9.41	-17.93
Basic EPS from Cont Ops	-15.79	-24.33	-83.92	-36.51	-49.77	-43.8	-42.15	-47.11	-48.32	-40.87	-24.75	-30.28	-18.79	-9.41	-17.93
Diluted EPS, GAAP	-15.79	-24.33	-83.92	-36.51	-49.77	-43.8	-42.15	-47.11	-48.32	-40.87	-24.75	-30.28	-18.79	-9.04	-17.93
Diluted EPS from Cont Ops	-15.79	-24.33	-83.92	-36.51	-49.77	-43.8	-42.15	-47.11	-48.32	-40.87	-24.75	-30.28	-18.79	-9.04	-17.93
Dividend per Share	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Cash Flow per Share	-13.09	-23.75	-74.88	-24.79	-39.6	-33.74	-24.09	-42.02	-46.2	-33.36	-21.36	-27.4	-12.17	-15.69	-6.89
Free Cash Flow per Basic Share	-13.66	-23.93	-75.02	-26.15	-40.19	-33.76	-24.11	-42.64	-46.25	-33.39	-22.5	-27.42	-12.17	-15.71	-6.89
Cash & Equivalents per Share	3.4	0.2	79.07	94.37	73.46	46.39	44.35	80.93	60.11	50.57	45.27	36.83	24.99	12.92	3.48
Book Value per Share	-6.61	-14.55	78.55	94.86	82.96	58.1	39.21	45.17	11.42	10.26	-15.78	-2.21	-17.78	-22.11	-16
Tangible Book Value per Share	-6.61	-14.55	78.55	94.86	82.96	58.1	39.21	45.17	11.42	10.26	-15.78	-2.21	-17.78	-22.11	-16

Karyopharm Therapeutics Inc.

Profitability (USD)

Credit (USD)

Liquidity (USD)

Working Capital (USD)

Enterprise Value (USD)

Multiples (USD)

Per Share Data Items (USD)